E-viri
Recenzirano
-
Gibbons, Krystal; Hu, Yiran B; Podsadecki, Thomas; Eron, Joseph J; Fredrick, Linda; Sulkowski, Mark S; Slim, Jihad; Ruane, Peter J; Wyles, David; Lalezari, Jay; Gathe, Joseph; Brennan, Robert; Da Silva-Tillmann, Barbara; Schnell, Gretja; Blick, Gary; Wang, Chia; Khatri, Amit; Bhatti, Laveeza; Campbell, Andrew L; Elion, Richard; Trinh, Roger; Bredeek, Fritz; McGovern, Barbara; Tripathi, Rakesh; Pilot-Matias, Tami
JAMA : the journal of the American Medical Association, 03/2015, Letnik: 313, Številka: 12Journal Article
The article reports on a study to evaluate the efficacy of Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavarin as a form of treatment for hepatitis C in patients co-infected with HIV-1. The results indicate that this form of treatment resulted in high sustained virologic response (SVR) rates among these patients.
